Biotech, or biotechnology, refers to the use of living organisms or their systems to develop products, often in the fields of medicine, agriculture, and environmental science.

Eli Lilly and Company is a global pharmaceutical company known for its innovative medicines and commitment to improving patient outcomes through research and development.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

France has had no request for investment approval in biotech abivax - official

Published by Global Banking & Finance Review®

Posted on January 12, 2026

1 min read

Last updated: January 20, 2026

Russian bomb factory acquiring Siemens technology amid sanctions - Global Banking & Finance Review — Image illustrating the Biysk Oleum Factory's acquisition of Siemens equipment via intermediaries, highlighting the circumvention of Western sanctions. This reflects ongoing military production efforts in Russia.

France has had no request for investment approval in biotech abivax - official

Quick Summary

France's Finance Ministry Confirms No Investment Requests for Abivax

Investment Approval Status for Abivax

Official Statement from Finance Ministry

Key Takeaways

Frequently Asked Questions about France has had no request for investment approval in biotech Abivax - official